Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons in oncology

P J Woll1, R Pettengell

  • 1Department of Clinical Oncology, University of Nottingham.

The British Journal of Clinical Practice
|March 1, 1997
PubMed
Summary

Interferons, glycoproteins with antiviral effects, are established treatments for certain leukemias and myeloma. Their use in solid tumors like lung and colorectal cancer remains experimental, with ongoing research into multi-modality treatment applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Bone marrow transplantation·2021
Same author

Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial.

Journal of cancer survivorship : research and practice·2020
Same author

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Lymphoma survivors' experience of participation in a home-based intervention post-chemotherapy.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2019
Same author

The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey.

European journal of cancer care·2016
Same author

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.

European journal of cancer (Oxford, England : 1990)·2014

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Interferons are natural glycoproteins with antiviral, antiproliferative, and immunomodulatory properties.
  • Recombinant human interferons are utilized in treating various malignancies.
  • Established efficacy in hairy cell leukemia, chronic myelogenous leukemia, and multiple myeloma.

Purpose of the Study:

  • To summarize the clinical applications of interferons in oncology.
  • To evaluate the role of interferons in multi-modality cancer treatment.
  • To review randomized studies on interferon efficacy in malignancies.

Main Methods:

  • Review of randomized clinical trials and practice applications.
  • Focus on oncological uses, excluding antiviral and immunomodulatory roles in non-cancer diseases.
  • Synthesis of evidence for interferon's place in cancer therapy.

Main Results:

  • Interferons are well-established for hematologic malignancies like leukemia and myeloma.
  • Documented activity in lymphoma, melanoma, renal cell cancer, and carcinoid tumors, though role is less clear.
  • Use in common solid tumors (lung, colorectal cancer) is still experimental.

Conclusions:

  • Interferons have a defined role in specific hematologic cancers.
  • Further research is needed to clarify their utility in solid tumors and as part of multi-modality treatment regimens.
  • The application of interferons in oncology is evolving, with ongoing investigation into their therapeutic potential.

Related Experiment Videos